Velan-Capital-Investment-Management-Lp

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
47
Total Value
90023167
Accession Number
0000938552-25-000003
Form Type
13F-HR
Manager Name
Velan-Capital-Investment-Management-Lp
Data Enrichment
94% identified
44 identified3 unidentified

Holdings

47 positions • $90.0M total value
Manager:
Search and click to pin securities to the top
Page 2 of 3
Immunome Inc.
Shares:153.5K
Value:$1.0M
% of Portfolio:1.1% ($1.0M/$90.0M)
TELA Bio, Inc.
Shares:747.4K
Value:$911.8K
% of Portfolio:1.0% ($911.8K/$90.0M)
Avalo Therapeutics, Inc.
Shares:112.0K
Value:$896.9K
% of Portfolio:1.0% ($896.9K/$90.0M)
SUTRO BIOPHARMA, INC.
Shares:1.0M
Value:$670.1K
% of Portfolio:0.7% ($670.1K/$90.0M)
Upstream Bio, Inc.
Shares:107.0K
Value:$654.8K
% of Portfolio:0.7% ($654.8K/$90.0M)
TENAX THERAPEUTICS, INC.
Shares:83.3K
Value:$545.8K
% of Portfolio:0.6% ($545.8K/$90.0M)
49721T507
Shares:122.2K
Value:$367.9K
% of Portfolio:0.4% ($367.9K/$90.0M)
Corbus Pharmaceuticals Holdings, Inc.
Shares:59.0K
Value:$313.3K
% of Portfolio:0.3% ($313.3K/$90.0M)
Regulus Therapeutics Inc.
Shares:80.0K
Value:$140.0K
% of Portfolio:0.2% ($140.0K/$90.0M)
Wave Life Sciences Ltd.
Shares:13.0K
Value:$105.0K
% of Portfolio:0.1% ($105.0K/$90.0M)
Gossamer Bio, Inc.
Shares:75.0K
Value:$82.5K
% of Portfolio:0.1% ($82.5K/$90.0M)
Erasca, Inc.
Shares:50.0K
Value:$68.5K
% of Portfolio:0.1% ($68.5K/$90.0M)
Alector, Inc.
Shares:55.0K
Value:$67.7K
% of Portfolio:0.1% ($67.7K/$90.0M)
Larimar Therapeutics, Inc.
Shares:28.0K
Value:$60.2K
% of Portfolio:0.1% ($60.2K/$90.0M)
ProQR Therapeutics N.V.
Shares:45.0K
Value:$59.9K
% of Portfolio:0.1% ($59.9K/$90.0M)
Context Therapeutics Inc.
Shares:90.0K
Value:$55.1K
% of Portfolio:0.1% ($55.1K/$90.0M)
Design Therapeutics, Inc.
Shares:14.0K
Value:$54.0K
% of Portfolio:0.1% ($54.0K/$90.0M)
Aclaris Therapeutics, Inc.
Shares:35.0K
Value:$53.5K
% of Portfolio:0.1% ($53.5K/$90.0M)
CytomX Therapeutics, Inc.
Shares:75.0K
Value:$47.7K
% of Portfolio:0.1% ($47.7K/$90.0M)
Terns Pharmaceuticals, Inc.
Shares:17.0K
Value:$46.9K
% of Portfolio:0.1% ($46.9K/$90.0M)